Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients

被引:0
|
作者
Meier-Stiegen, F. [1 ]
Schneck, H. [1 ]
Blassl, C. [1 ]
Neves, R. Pedro [2 ]
Janni, W. [3 ]
Fehm, T. [1 ]
Neubauer, H. [1 ]
机构
[1] Univ Frauenklin Dusseldorf, Forschungslab Life Sci Ctr, Dusseldorf, Germany
[2] Univ Dusseldorf, Dusseldorf, Germany
[3] Univ Frauenklin Ulm, Ulm, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:5 / 5
页数:1
相关论文
共 50 条
  • [41] Exploring the intra-patient PIK3CA mutational heterogeneity of circulating tumour cells by massive parallel sequencing in patients with metastatic hormone receptor-positive breast cancer.
    De Laere, Bram
    Peeters, Dieter J. E.
    Salgado, Roberto
    Vermeulen, Peter B.
    van Dam, Peter A.
    Van Laere, Steven J.
    Dirix, Luc Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] Possibility of PIK3CA mutation in circulating tumor DNA from early stage breast cancer patients as a predictive indicator for poor prognosis
    Sato, A.
    Tanabe, M.
    Tsuboi, Y.
    Kikuchi, Y.
    Ikemura, M.
    Niwa, T.
    Nishioka, K.
    Tada, K.
    Murakami, Y.
    Seto, Y.
    BREAST, 2019, 44 : S29 - S30
  • [43] Survey of KRAS, BRAF and PIK3CA mutational status in 209 consecutive Italian colorectal cancer patients
    Bozzao, Cristina
    Varvara, Dora
    Piglionica, Marilidia
    Bagnulo, Rosanna
    Forte, Giovanna
    Patruno, Margherita
    Russo, Silvana
    Piscitelli, Domenico
    Stella, Alessandro
    Resta, Nicoletta
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2012, 27 (04): : E366 - E374
  • [44] Novel Method for Detection of PIK3CA Mutations in Circulating Tumor DNA of Patients with Colorectal Cancer
    Pu, Wangyang
    Wang, Fengjiao
    Li, Kai
    Xing, Chungen
    Zhuang, Zhixiang
    Wang, Hui
    Bian, Huahui
    Zhang, Rong
    Xiao, Li
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2023, 195 (12) : 7821 - 7831
  • [45] Novel Method for Detection of PIK3CA Mutations in Circulating Tumor DNA of Patients with Colorectal Cancer
    Wangyang Pu
    Fengjiao Wang
    Kai Li
    Chungen Xing
    Zhixiang Zhuang
    Hui Wang
    Huahui Bian
    Rong Zhang
    Li Xiao
    Applied Biochemistry and Biotechnology, 2023, 195 : 7821 - 7831
  • [46] PIK3CA mutation status in Japanese lung cancer patients
    Kawano, Osamu
    Sasaki, Hidefumi
    Endo, Katsuhiko
    Suzuki, Eriko
    Haneda, Hiroshi
    Yukiue, Haruhiro
    Kobayashi, Yoshihiro
    Yano, Motoki
    Fujii, Yoshitaka
    LUNG CANCER, 2006, 54 (02) : 209 - 215
  • [47] EVALUATION OF PTEN AND PIK3CA STATUS IN BREAST CANCER FOR PATIENT SELECTION
    Serra, V.
    Rodon, J.
    Aura, C. M.
    Vivancos, A.
    Stemke-Hale, K.
    Hibshoosh, H.
    Wang, Y.
    Ramon Y Cajal, S.
    Tabernero, J.
    Baselga, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 84 - 84
  • [48] PIK3CA mutation profiling in Vietnamese patients with breast cancer
    Vuong, Linh Dieu
    Ta, To Van
    Chu, Ha Hoang
    Truong, Van-Long
    Nguyen, Quang Ngoc
    META GENE, 2020, 25
  • [49] Clinical application of mutational analysis in breast cancer patients: The relevance of PIK3CA analysis for precision medicine
    Cejalvo, J. M.
    Moragon, S.
    Ortega, B.
    Hernando, C.
    Martinez, M.
    Gambardella, V.
    Tarazona Llavero, N.
    Roda, D.
    Burgues, O.
    Alonso, E.
    Simon, S.
    Poveda, J.
    Rentero, P.
    Zuniga, S.
    Bermejo, B.
    Lluch, A.
    Cervantes, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [50] Study of single live circulating tumor cells capture and their genomic profile and enriched mutations of PIK3CA and HRR pathway in patients with breast cancer
    Khandare, Jayant
    Bharde, Atul
    Kishore, Sirish
    Andhari, Saloni
    Khutale, Ganesh
    Jadhav, Bhagwat
    Prajapati, Sangeeta
    Zhou, Wenhui
    Mobeen, Fauzul
    Hariramani, Kanchan
    Basavalingegowda, Madhura
    Jadhav, Vikas Leelavati Balasaheb
    Uttarwar, Mohan
    Joshi, Ashish
    Ghadyalpatil, Nikhil
    Velkuru, Sai Vivek
    Thirumalairaj, Raja
    Shafi, Gowhar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)